Advances and Utility of the Human Plasma Proteome.
暂无分享,去创建一个
Philipp E. Geyer | R. Moritz | G. Omenn | E. Deutsch | J. Schwenk | Michal Maes | M. Pernemalm | Zhi Sun | S. Tao | Y. Vandenbrouck | V. Brun | V. Ignjatovic | Xiaobo Yu | Natasha Letunica | K. K. Palaniappan
[1] Calliope A. Dendrou,et al. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity , 2021, Cell.
[2] R. Aebersold,et al. Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project. , 2021, Journal of proteome research.
[3] L. Reiter,et al. Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area , 2021, bioRxiv.
[4] F. Edfors,et al. Targeted proteomics analysis of plasma proteins using recombinant protein standards for addition only workflows. , 2021, BioTechniques.
[5] K. V. van Wijk,et al. The Arabidopsis PeptideAtlas: Harnessing worldwide proteomics data to create a comprehensive community proteomics resource. , 2021, The Plant cell.
[6] R. Vasan,et al. Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients. , 2021, Translational research : the journal of laboratory and clinical medicine.
[7] H. Tegel,et al. Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay , 2021, Clinical & translational immunology.
[8] Maximilian T. Strauss,et al. High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion , 2021, EMBO molecular medicine.
[9] B. Lehallier,et al. The protein inputs of an ultra-predictive aging clock represent viable anti-aging drug targets , 2021, Ageing Research Reviews.
[10] Henk W. P. van den Toorn,et al. A serum proteome signature to predict mortality in severe COVID-19 patients , 2021, Life Science Alliance.
[11] Caizheng Yu,et al. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins , 2021, Cell Reports.
[12] F. Edfors,et al. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms , 2021, EBioMedicine.
[13] J. Schwenk,et al. Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2 , 2021, Nature Communications.
[14] Christoph B. Messner,et al. A time-resolved proteomic and prognostic map of COVID-19 , 2021, Cell Systems.
[15] Jennifer G. Abelin,et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs , 2021, Cell.
[16] D. O’Connor,et al. The landscape of antibody binding in SARS-CoV-2 infection , 2021, PLoS biology.
[17] Jae Hyeon Park,et al. Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID‐19 progression , 2021, Proteomics.
[18] G. Bergström,et al. Next generation plasma proteome profiling to monitor health and disease , 2021, Nature Communications.
[19] Paul J. Hoover,et al. Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions , 2021, Cell Reports Medicine.
[20] M. Uhlén,et al. Blood protein profiles related to preterm birth and retinopathy of prematurity , 2021, Pediatric Research.
[21] D. Hafler,et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children , 2021, Immunity.
[22] M. Addo,et al. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series , 2021, Pathogens.
[23] M. McCarthy,et al. Genetic analysis of blood molecular phenotypes reveals regulatory networks affecting complex traits: a DIRECT study. , 2021, medRxiv.
[24] Christoph B. Messner,et al. Ultra-fast proteomics with Scanning SWATH , 2021, Nature Biotechnology.
[25] M. Müller,et al. SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients , 2021, Frontiers in Immunology.
[26] A. Hingorani,et al. Cross-platform proteomics to advance genetic prioritisation strategies , 2021, bioRxiv.
[27] J. Schwenk,et al. Circulating proteins associated with allergy development in infants—an exploratory analysis , 2021, Clinical proteomics.
[28] K. Schenke-Layland,et al. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals , 2021, Nature Communications.
[29] E. Deutsch,et al. Data Management of Sensitive Human Proteomics Data: Current Practices, Recommendations, and Perspectives for the Future , 2021, Molecular & cellular proteomics : MCP.
[30] Xiaodong Zhao,et al. Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution , 2021, Cellular & Molecular Immunology.
[31] G. Omenn. Reflections on the HUPO Human Proteome Project, the Flagship Project of the Human Proteome Organization, at 10 Years , 2021, Molecular & cellular proteomics : MCP.
[32] C. Greenwood,et al. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity , 2021, Nature Medicine.
[33] H. Rammensee,et al. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity , 2021, Nature Communications.
[34] Yohann Couté,et al. Well Plate Maker: a user-friendly randomized block design application to limit batch effects in large-scale biomedical studies , 2021, Bioinform..
[35] S. Chakrabortty,et al. Exosome-based liquid biopsies in cancer: opportunities and challenges , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] L. Joosten,et al. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19. , 2021, The Journal of infectious diseases.
[37] H. Shan,et al. Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients , 2021, Cellular & Molecular Immunology.
[38] B. Parker,et al. Proteome-wide Systems Genetics to Identify Functional Regulators of Complex Traits. , 2021, Cell systems.
[39] Philipp E. Geyer,et al. Ethical Principles, Constraints, and Opportunities in Clinical Proteomics , 2021, Molecular & cellular proteomics : MCP.
[40] Wout Bittremieux,et al. Universal Spectrum Identifier for mass spectra , 2020, Nature Methods.
[41] P. Sebastiani,et al. Effect of Longevity Genetic Variants on the Molecular Aging Rate , 2020, GeroScience.
[42] K. Schnatbaum,et al. Peptide microarray‐based analysis of antibody responses to SARS‐CoV‐2 identifies unique epitopes with potential for diagnostic test development , 2020, medRxiv.
[43] Caizheng Yu,et al. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients , 2020, Cell Reports.
[44] Toshiko Tanaka,et al. Protein signatures of centenarians and their offspring suggest centenarians age slower than other humans , 2019, Aging cell.
[45] F. Revol-Cavalier,et al. PepS: An Innovative Microfluidic Device for Bedside Whole Blood Processing before Plasma Proteomics Analyses. , 2020, Analytical chemistry.
[46] B. Thorand,et al. Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling. , 2020, Journal of proteome research.
[47] Toshiko Tanaka,et al. Characterization of the plasma proteomic profile of frailty phenotype , 2020, GeroScience.
[48] E. Holmes,et al. Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage , 2020, The EMBO journal.
[49] Mark M. Davis,et al. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19 , 2020, Cell.
[50] N. Barzilai,et al. Plasma proteomic profile of age, health span, and all‐cause mortality in older adults , 2020, Aging cell.
[51] C. Giaquinto,et al. Virological and Immunological Features of SARS-CoV-2 Infected Children Developing Specific and Neutralizing Antibodies , 2020, SSRN Electronic Journal.
[52] Yang Han,et al. Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19 , 2020, Immunity.
[53] Yang Zhang,et al. Progressive and accurate assembly of multi-domain protein structures from cryo-EM density maps , 2020, bioRxiv.
[54] Rebekah L. Gundry,et al. A high-stringency blueprint of the human proteome , 2020, Nature Communications.
[55] B. Zhang,et al. Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections , 2020, Allergy.
[56] T. Wyss-Coray,et al. Data mining of human plasma proteins generates a multitude of highly predictive aging clocks that reflect different aspects of aging , 2020, Aging cell.
[57] J. Nielsen,et al. Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19 , 2020, medRxiv.
[58] J. Danesh,et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals , 2020, Nature Metabolism.
[59] N. Hacohen,et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity , 2020, Science.
[60] Eric W. Deutsch,et al. Research on The Human Proteome Reaches a Major Milestone: >90% of Predicted Human Proteins Now Credibly Detected, according to the HUPO Human Proteome Project. , 2020, Journal of proteome research.
[61] V. Tremaroli,et al. Integration of molecular profiles in a longitudinal wellness profiling cohort , 2020, Nature Communications.
[62] M. McCarthy,et al. Genetics meets proteomics: perspectives for large population-based studies , 2020, Nature reviews. Genetics.
[63] L. Milani,et al. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 , 2020, Scientific Reports.
[64] D. Kondziella,et al. Extracellular vesicles in patients in the acute phase of psychosis and after clinical improvement: an explorative study , 2020, PeerJ.
[65] Amber L. Simpson,et al. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers , 2020, Cell.
[66] N. Barzilai,et al. Plasma proteomic profile of frailty , 2020, Aging cell.
[67] P. Hall,et al. Profiles of histidine-rich glycoprotein associate with age and risk of all-cause mortality , 2020, Life Science Alliance.
[68] Ryan W. Benz,et al. Rapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona , 2020, Nature Communications.
[69] Dong Men,et al. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses , 2020, Nature Communications.
[70] Michael J. Purcaro,et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes , 2020, Nature.
[71] Maohui Luo,et al. Proteomics Uncovers Immunosuppression in COVID-19 Patients with Long Disease Course , 2020, medRxiv.
[72] Y. Li,et al. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients , 2020, Cellular & Molecular Immunology.
[73] Christoph B. Messner,et al. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection , 2020, Cell Systems.
[74] E. Hod,et al. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level , 2020, medRxiv.
[75] Q. Zhang,et al. Age-Dependent Changes in the Plasma Proteome of Healthy Adults , 2020, The journal of nutrition, health & aging.
[76] A. Reiner,et al. Comparison of Proteomic Assessment Methods in Multiple Cohort Studies , 2020, Proteomics.
[77] James R. Staley,et al. Coding and regulatory variants affect serum protein levels and common disease , 2020, bioRxiv.
[78] J. Lehtiö,et al. In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma , 2020, Journal for immunotherapy of cancer.
[79] Benjamin J. Polacco,et al. A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.
[80] J. V. Van Eyk,et al. A Plasma Sample Preparation for Mass Spectrometry using an Automated Workstation. , 2020, Journal of visualized experiments : JoVE.
[81] M. Uhlén,et al. Dramatic changes in blood protein levels during the first week of life in extremely preterm infants , 2020, Pediatric Research.
[82] T. Wyss-Coray,et al. Systematic review and analysis of human proteomics aging studies unveils a novel proteomic aging clock and identifies key processes that change with age , 2020, Ageing Research Reviews.
[83] Huanhuan Gao,et al. Proteomic and Metabolomic Characterization of COVID-19 Patient Sera , 2020, Cell.
[84] Xiaobo Yu,et al. SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution , 2020, bioRxiv.
[85] G. Bergström,et al. Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling , 2020, bioRxiv.
[86] Richard D. Smith,et al. NCI Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant Lesions. , 2020, Journal of proteome research.
[87] H. Hampel,et al. Successful aging: insights from proteome analyses of healthy centenarians , 2020, Aging.
[88] R. Marioni,et al. Neurology-related protein biomarkers are associated with cognitive ability and brain volume in older age , 2020, Nature Communications.
[89] W. Stoorvogel,et al. A novel three step protocol to isolate extracellular vesicles from plasma or cell culture medium with both high yield and purity , 2020, Journal of extracellular vesicles.
[90] Radu Popescu,et al. A fully joint Bayesian quantitative trait locus mapping of human protein abundance in plasma , 2019, PLoS Comput. Biol..
[91] C. Lindskog,et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells , 2019, Science.
[92] K. Hajela,et al. Identification of unexplored substrates of the serine protease, thrombin, using N-terminomics strategy. , 2019, International journal of biological macromolecules.
[93] J. Behrends,et al. Electrical recognition of the twenty proteinogenic amino acids using an aerolysin nanopore , 2019, Nature Biotechnology.
[94] L. Reubsaet,et al. All-in-one paper-based sampling chip for targeted protein analysis. , 2019, Analytica chimica acta.
[95] Stephen A. Williams,et al. Plasma protein patterns as comprehensive indicators of health , 2019, Nature Medicine.
[96] Devin P. Sullivan,et al. The human secretome , 2019, Science Signaling.
[97] John C. Earls,et al. Multi-Omic Biological Age Estimation and Its Correlation With Wellness and Disease Phenotypes: A Longitudinal Study of 3,558 Individuals. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.
[98] Andreas Keller,et al. Undulating changes in human plasma proteome profiles across the lifespan , 2019, Nature Medicine.
[99] Yves Vandenbrouck,et al. Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer , 2019, Proteomics.
[100] Guo Ci Teo,et al. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma , 2019, Cell.
[101] Matthias Mann,et al. Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies , 2019, EMBO molecular medicine.
[102] J. Wiśniewski,et al. Plasma fibrin clot proteomics in healthy subjects: Relation to clot permeability and lysis time. , 2019, Journal of proteomics.
[103] Mats Nilsson,et al. Profiling surface proteins on individual exosomes using a proximity barcoding assay , 2019, Nature Communications.
[104] Eric W. Deutsch,et al. Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 3.0 , 2019, bioRxiv.
[105] José González-Valdez,et al. Recent advances and challenges in the recovery and purification of cellular exosomes , 2019, Electrophoresis.
[106] Gilbert S. Omenn,et al. Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data , 2019, bioRxiv.
[107] Yeheng Liu,et al. Plasma proteomic and autoantibody profiles reveal the proteomic characteristics involved in longevity families in Bama, China , 2019, Clinical Proteomics.
[108] J. Wiśniewski,et al. Comparison of Proteome Composition of Serum Enriched in Extracellular Vesicles Isolated from Polycythemia Vera Patients and Healthy Controls , 2019, Proteomes.
[109] Subha Madhavan,et al. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities , 2019, Cell.
[110] Cheng Chang,et al. In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine , 2019, Theranostics.
[111] Olga Tanaseichuk,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[112] E. Critselis. Impact of the General Data Protection Regulation on Clinical Proteomics Research , 2019, Proteomics. Clinical applications.
[113] A. Voet,et al. FraC nanopores with adjustable diameter identify the mass of opposite-charge peptides with 44 dalton resolution , 2019, Nature Communications.
[114] G. Bergström,et al. Individual and stable autoantibody repertoires in healthy individuals , 2019, Autoimmunity.
[115] T. Andresen,et al. What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer. , 2019, Biochimica et biophysica acta. Reviews on cancer.
[116] D. Yellon,et al. Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential , 2018, Journal of extracellular vesicles.
[117] Yves Vandenbrouck,et al. Designing an In Silico Strategy to Select Tissue-Leakage Biomarkers Using the Galaxy Framework. , 2019, Methods in molecular biology.
[118] Yeheng Liu,et al. TMT‐Based Quantitative Proteomic Analysis Reveals Proteomic Changes Involved in Longevity , 2018, Proteomics. Clinical applications.
[119] J. Wiśniewski,et al. Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism , 2018, Scientific Reports.
[120] Edward M Marcotte,et al. Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures , 2018, Nature Biotechnology.
[121] Luis Mendoza,et al. Flexible and Fast Mapping of Peptides to a Proteome with ProteoMapper. , 2018, Journal of proteome research.
[122] Xia Yang,et al. Co-regulatory networks of human serum proteins link genetics to disease , 2018, Science.
[123] Taura L. Barr,et al. High-throughput profiling of the circulating proteome suggests sexually dimorphic corticosteroid signaling following ischemic stroke. , 2018, Physiological genomics.
[124] A. Moore,et al. Plasma proteomic signature of age in healthy humans , 2018, Aging cell.
[125] Stephen Burgess,et al. Genomic atlas of the human plasma proteome , 2018, Nature.
[126] L. Baumbusch,et al. Prospective plasma proteome changes in preterm infants with different gestational ages , 2018, Pediatric Research.
[127] Daniel J. Blankenberg,et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update , 2018, Nucleic Acids Res..
[128] Nam-Trung Nguyen,et al. Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles. , 2018, Small.
[129] M. Lesperance,et al. Differential Proteomics for Distinguishing Ischemic Stroke from Controls: a Pilot Study of the SpecTRA Project , 2018, Translational Stroke Research.
[130] Graça Raposo,et al. Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.
[131] Pieter Vermeersch,et al. Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma , 2018, Journal of Translational Medicine.
[132] A. Astrup,et al. The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention , 2018, Proteomics. Clinical applications.
[133] R. Aebersold,et al. The Human Plasma Proteome Draft of 2017: Building on the Human Plasma PeptideAtlas from Mass Spectrometry and Complementary Assays. , 2017, Journal of proteome research.
[134] Eric Boerwinkle,et al. Whole-genome sequencing study of serum peptide levels: the Atherosclerosis Risk in Communities study , 2017, Human molecular genetics.
[135] Martin Eisenacher,et al. Proteomics Standards Initiative: Fifteen Years of Progress and Future Work , 2017, Journal of proteome research.
[136] Hasmik Keshishian,et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry , 2017, Nature Protocols.
[137] John C. Earls,et al. A wellness study of 108 individuals using personal, dense, dynamic data clouds , 2017, Nature Biotechnology.
[138] Mathieu Schaeffer,et al. The neXtProt peptide uniqueness checker: a tool for the proteomics community , 2017, Bioinform..
[139] Jian-Kang Zhu,et al. Phosphoproteins in extracellular vesicles as candidate markers for breast cancer , 2017, Proceedings of the National Academy of Sciences.
[140] Peter Nilsson,et al. Whole-Proteome Peptide Microarrays for Profiling Autoantibody Repertoires within Multiple Sclerosis and Narcolepsy. , 2017, Journal of proteome research.
[141] D. Trégouët,et al. PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. , 2016, Blood.
[142] Matthias Mann,et al. Proteomics reveals the effects of sustained weight loss on the human plasma proteome , 2016, Molecular systems biology.
[143] Luis Mendoza,et al. Tiered Human Integrated Sequence Search Databases for Shotgun Proteomics. , 2016, Journal of proteome research.
[144] Lennart Martens,et al. Human Proteome Project Mass Spectrometry Data Interpretation Guidelines 2.1. , 2016, Journal of proteome research.
[145] Michael L. Gatza,et al. Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.
[146] Matthias Mann,et al. Plasma Proteome Profiling to Assess Human Health and Disease. , 2016, Cell systems.
[147] S. Shinkai,et al. Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age‐related disorders , 2016, Geriatrics & gerontology international.
[148] Luis Mendoza,et al. Trans‐Proteomic Pipeline, a standardized data processing pipeline for large‐scale reproducible proteomics informatics , 2015, Proteomics. Clinical applications.
[149] Heng Zhu,et al. Autoantibody Profiling on Human Proteome Microarray for Biomarker Discovery in Cerebrospinal Fluid and Sera of Neuropsychiatric Lupus , 2015, PloS one.
[150] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[151] Magda Tsolaki,et al. Circulating Proteomic Signatures of Chronological Age , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.
[152] A. Nesvizhskii. Proteogenomics: concepts, applications and computational strategies , 2014, Nature Methods.
[153] G. Raskob,et al. Thrombosis: a major contributor to the global disease burden , 2014, Journal of thrombosis and haemostasis : JTH.
[154] Larry Gold,et al. Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents , 2014, Molecular therapy. Nucleic acids.
[155] M. Yáñez-Mó,et al. Tetraspanins in Extracellular Vesicle Formation and Function , 2014, Front. Immunol..
[156] Ulf Gyllensten,et al. Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs , 2014, Nature Communications.
[157] U. Landegren,et al. Protein biomarker validation via proximity ligation assays. , 2014, Biochimica et biophysica acta.
[158] J. Stenvang,et al. Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability , 2014, PloS one.
[159] Mary F. Lopez,et al. Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms. , 2014, Journal of proteome research.
[160] Eric W Deutsch,et al. State of the human proteome in 2013 as viewed through PeptideAtlas: comparing the kidney, urine, and plasma proteomes for the biology- and disease-driven Human Proteome Project. , 2014, Journal of proteome research.
[161] Manuel Serrano,et al. The Hallmarks of Aging , 2013, Cell.
[162] Stefan Enroth,et al. Identification of genetic variants influencing the human plasma proteome , 2013, Proceedings of the National Academy of Sciences.
[163] J. Eng,et al. Comet: An open‐source MS/MS sequence database search tool , 2013, Proteomics.
[164] N. Anderson,et al. The riddle of protein diagnostics: future bleak or bright? , 2013, Clinical chemistry.
[165] R. Tanzi. The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[166] Gema Moreno-Bueno,et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.
[167] E. Diamandis,et al. Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery , 2012, BMC Medicine.
[168] Amos Bairoch,et al. neXtProt: a knowledge platform for human proteins , 2011, Nucleic Acids Res..
[169] Yang Zhang,et al. Functional implications of structural predictions for alternative splice proteins expressed in Her2/neu-induced breast cancers. , 2011, Journal of proteome research.
[170] N. L. Anderson. Counting the proteins in plasma. , 2010, Clinical chemistry.
[171] P. Ramachandran,et al. Comparative Human Salivary and Plasma Proteomes , 2010, Journal of dental research.
[172] Luis Mendoza,et al. Trans‐Proteomic Pipeline supports and improves analysis of electron transfer dissociation data sets , 2010, Proteomics.
[173] S. Mathivanan,et al. ExoCarta: A compendium of exosomal proteins and RNA , 2009, Proteomics.
[174] P. James,et al. Strategy for surveying the proteome using affinity proteomics and mass spectrometry , 2009, Proteomics.
[175] Dieter Stoll,et al. Proteome wide screening using peptide affinity capture , 2009, Proteomics.
[176] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[177] R. Aebersold,et al. A uniform proteomics MS/MS analysis platform utilizing open XML file formats , 2005, Molecular systems biology.
[178] Nichole L. King,et al. Human Plasma PeptideAtlas , 2005, Proteomics.
[179] Eugene A. Kapp,et al. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.
[180] Nichole L. King,et al. Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry , 2004, Genome Biology.
[181] Jonas Jarvius,et al. Cytokine detection by antibody-based proximity ligation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[182] Rolf Apweiler,et al. The HUPO Proteomics Standards Initiative Meeting: Towards Common Standards for Exchanging Proteomics Data , 2003, Comparative and functional genomics.
[183] Alexey I Nesvizhskii,et al. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.